中集環科(301559.SZ):成功進入西門子、飛利浦、聯影醫療、健信核磁等醫療磁共振設備市場行業龍頭企業供應鏈體系
格隆匯11月27日丨中集環科(301559.SZ)於近期投資者關係活動表示,目前,公司醫療設備部件產品主要有筒體、封頭、組件等。公司在業內具有較強的品牌影響力,憑藉強大的封頭成型技術、金屬焊接技術、容器質保體系、質量控制能力,成功進入西門子、飛利浦、聯影醫療、健信核磁等醫療磁共振設備市場行業龍頭企業供應鏈體系。未來,公司將深耕醫療成像設備領域,強化產品研發能力建設,擴大公司產品深度與廣度,加強與主流客户深度合作,進一步做大做強市場,提升市場佔有率。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.